Cargando…

Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives

Since their introduction to pharmacotherapy, proton pump inhibitors (PPIs) have been widely used in the treatment of numerous diseases manifested by excessive secretion of gastric acid. Despite that, there are still unmet needs regarding their availability for patients of all age groups. Their poor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srebro, Justyna, Brniak, Witold, Mendyk, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612372/ https://www.ncbi.nlm.nih.gov/pubmed/36297478 http://dx.doi.org/10.3390/pharmaceutics14102043

Ejemplares similares

Formulation Challenges and Strategies to Develop Pediatric Dosage Forms
por: Malkawi, Wedad A., et al.
Publicado: (2022)

FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
por: Nair, Anroop B, et al.
Publicado: (2010)

Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms
por: Bernsen, Emma C., et al.
Publicado: (2022)

Formulation and Characterization of Patient-Friendly Dosage Form of Ondansetron Hydrochloride
por: Bhoyar, PK, et al.
Publicado: (2010)

Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology
por: Baral, Kshitis Chandra, et al.
Publicado: (2021)

Formulation and characterization of sustained release dosage form of moisture sensitive drug
por: Patel, Priya, et al.
Publicado: (2015)

Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form
por: Chikukwa, Mellisa T. R., et al.
Publicado: (2020)

Formulation of New Chewable Oral Dosage Forms of Meclizine and Pyridoxine Hydrochloride
por: Al-Madhagi, Wafa M., et al.
Publicado: (2023)

Anti-infective properties of proton pump inhibitors: perspectives
por: da Rosa, Taciéli Fagundes, et al.
Publicado: (2021)

HPLC Method for Estimation of Metformin Hydrochloride in Formulated Microspheres and Tablet Dosage Form
por: Kar, Mousumi, et al.
Publicado: (2009)

Empirical modeling of the fine particle fraction for carrier-based pulmonary delivery formulations
por: Pacławski, Adam, et al.
Publicado: (2015)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Prescribing efficiency of proton pump inhibitors in China: influence and future directions
por: Zeng, Wenjie, et al.
Publicado: (2015)

Formulation and In vitro Evaluation of Sustained Release Dosage Form with Taste Masking of Metformin Hydrochloride
por: Bhoyar, P. K., et al.
Publicado: (2010)

Formulation and evaluation of pH activated dosage form as minitablets in capsule for delivery of fesoterodine
por: Syed, Shoaeb M., et al.
Publicado: (2021)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

CAR-T State of the Art and Future Challenges, A Regulatory Perspective
por: Giorgioni, Lorenzo, et al.
Publicado: (2023)

An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
por: Homolak, Jan, et al.
Publicado: (2021)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs)
por: Brniak, Witold, et al.
Publicado: (2015)

Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms
por: Salamanca, Constain H., et al.
Publicado: (2018)

Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca
por: Brown, Teagan L., et al.
Publicado: (2017)

Solid Dosage Forms of Dexamethasone Sodium Phosphate Intended for Pediatric Use: Formulation and Stability Studies
por: Synaridou, Maria S., et al.
Publicado: (2020)

Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations
por: Cornilă, Andreea, et al.
Publicado: (2022)

Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse
por: Savarino, Edoardo, et al.
Publicado: (2022)

Pasteurization as a tool to control the bio-burden in solid herbal dosage forms: A pilot study of formulating Ashoka tablets with an industrial perspective
por: Pushpalatha, Hulikal Basavarajaiah, et al.
Publicado: (2014)

The Dosage Form of Aragh in Treatment, from the Iranian Traditional Medicine Perspective
por: Adl, Mehdi, et al.
Publicado: (2016)

Photocatalytic Conversion of Methane: Current State of the Art, Challenges, and Future Perspectives
por: Liu, Zhuo, et al.
Publicado: (2023)

The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives
por: Coffetti, Giulia, et al.
Publicado: (2023)

Pharmaceutical dosage forms : parenteral medications /
Publicado: (1992)

Pharmaceutical dosage forms : disperse systems
Publicado: (1996)

Formulation of Topical Dosage Forms Containing Synthetic and Natural Anti-Inflammatory Agents for the Treatment of Rheumatoid Arthritis
por: Jurca, Tunde, et al.
Publicado: (2020)

Formulation Strategies to Improve the Stability and Handling of Oral Solid Dosage Forms of Highly Hygroscopic Pharmaceuticals and Nutraceuticals
por: Ng, Liu Han, et al.
Publicado: (2022)

Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions
por: Franciosi, James P, et al.
Publicado: (2022)

Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors
por: Sharma, Shringi, et al.
Publicado: (2022)

Introduction to pharmaceutical dosage forms /
por: Ansel, Howard C., 1933-
Publicado: (1976)

Pharmaceutical dosage forms--tablets /
Publicado: (1989)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1sukqvh85p58qe7ani2tu5ke4f